title: Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: a two-center study.
abstract: OBJECTIVE
  Left ventricular assist device (LVAD) insertion after anterior wall myocardial infarction complicated by cardiogenic shock is an accepted modality of support in select patients. Results of primary revascularization for these patients are poor. We seek to determine the outcomes of patients with myocardial infarction and shock who undergo LVAD insertion alone versus surgical revascularization before LVAD insertion.
  
  
  METHODS
  Seventy-four patients at 2 institutions underwent LVAD implantation for myocardial infarction and shock over a 12-year period. Twenty-eight underwent direct LVAD placement, and 46 underwent revascularization through coronary artery bypass grafting before LVAD placement. Variables examined included patient demographics, myocardial infarction-LVAD interval, bridge to transplantation, early mortality (< or = 30 days), survival after LVAD placement, and posttransplantation survivals.
  
  
  RESULTS
  There were no differences in demographics between the 2 groups. The group undergoing revascularization before LVAD placement had a lower bridge to transplantation, higher early mortality, and lower overall 6- and 12-month survivals after LVAD placement compared with the group undergoing direct LVAD placement (45.50% vs 70.40%, P = .041; 39.10% vs 14.30%, P = .020; 89.3% and 82.1% vs 54.4% and 52.2%, respectively, P = .006). Posttransplantation survival and LVAD explantation rates were equivalent in both groups.
  
  
  CONCLUSIONS
  Coronary artery bypass grafting before LVAD insertion for cardiogenic shock complicating myocardial infarction adversely affects survival. Confirmation of these findings would require conducting a large, multicenter, randomized clinical trial comparing revascularization versus LVAD support as primary therapy in this setting.
authors.affiliation: Division of Cardiothoracic Surgery, Department of Surgery, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.
authors.forename: Nicholas C
authors.initials: NC
authors.lastname: Dang
authors.forename: Veli K
authors.initials: VK
authors.lastname: Topkara
authors.forename: Marzia
authors.initials: M
authors.lastname: Leacche
authors.forename: Ranjit
authors.initials: R
authors.lastname: John
authors.forename: John G
authors.initials: JG
authors.lastname: Byrne
authors.forename: Yoshifumi
authors.initials: Y
authors.lastname: Naka
mesh_terms: D001026:Coronary Artery Bypass; D005260:Female; D016027:Heart Transplantation / Q000401:mortality; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D012770:Shock, Cardiogenic / Q000209:etiology / Q000628:therapy*; D015996:Survival Rate